Assignee
SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECH CO LTD
CN·6 granted patents·5 citations·filing 2016–2017
Top patents by PatentIndex Score
6 records- 0185US10736920B2PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the sameSHANGHAI UNICAR-THERAPY BIO-MEDICINE TECH CO LTD·Filed 2017·Granted Aug 11, 2020·3 cites·20 claims
- 0282US11066680B2IL6R block CAR-T transgenic vector for alleviating CRS, preparation method thereofSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Jul 20, 2021·2 cites·10 claims
- 0356US11242530B2siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applicationsSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Feb 8, 2022·0 cites·19 claims
- 0453US10702552B2SiRNA of human IL-6 and recombinant expression CAR-T vector and their construction methods and applicationsSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2016·Granted Jul 7, 2020·0 cites·20 claims
- 0542US11098123B2OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereofSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Aug 24, 2021·0 cites·20 claims
- 0642US10934357B2Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereofSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Mar 2, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →